Clinical Trial Update: Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing pancreatic cancer patients with elevated CA125 who did or did not receive neoadjuvant chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Adenocarcinoma | Phase 3 | Status: UNKNOWN